flagship live product publicly visible through CerviGuard.
Healthcare AI companyCerviGuard live productDataGems live research pilot
Live cervical screening software, active research pilots, and public trust routes.
SmartClover is a Romania-based healthcare AI company building CerviGuard as its flagship live product and DataGems as a live research pilot. Named leadership, public cervical screening research, visible product surfaces, and clear commercial routes support evaluation by clinical, research, and investment stakeholders.
- Product proof:live product surface at cerviguard.link plus public repository and model hub references.
- Research continuity:PubMed references from 2017 and 2022 document continuity with cervical screening and follow-up research.
- Trust orientation:privacy, security, incident response, pricing, buying, proof, and regulatory routes remain public.
Authentic flagship proofThe live CerviGuard workspace demonstrates case review, operational oversight, and product maturity.
live research pilot publicly visible through DataGems.
publication anchors already visible through public PubMed references.
Product evidence and evaluation routes
SmartClover presents a flagship product, public research continuity, and direct access to trust and commercial materials for external review.
Live product
CerviGuard is the flagship product.
The live product surface, public repository, and trust routes make the cervical screening platform easy to evaluate.
Research continuity
Leadership and clinical research signals are public.
Two PubMed references connect SmartClover to Romanian cervical screening and follow-up research continuity.
Trust routes
Security, privacy, proof, and regulatory material stay visible.
Visitors can move from the homepage into trust, proof, pricing, and buying paths without leaving the public site.
A flagship product within a broader company platform
CerviGuard remains the primary commercial product, while the wider platform, research, and diligence surfaces keep the full company offering visible.
Flagship product
CerviGuard
A live product for structured cervical screening workflows, AI-assisted review, and clinician-led follow-up.
Live research pilot
DataGems
A live research pilot for governed synthetic-data generation using SLM-first execution with optional external APIs.
Public research directions
Cancer prevention and decision support
SmartClover publicly discusses cancer prevention, secondary prophylaxis, early detection, and treatment-optimization research as active directions, not as released products.
Founder and research credibility
Leadership, publications, and public artifacts support due diligence.
SmartClover's public profile references founder Dr. Andreea Damian, publication continuity that includes earlier work published as Andreea Itu, and cervical screening research involving Dr. Florian Nicula. These references provide named accountability for the company's healthcare focus.
PubMed 35197342 links directly to Romanian follow-up research in remote communities.PubMed 28460211 links directly to barriers in cervical screening participation in Romania.CerviGuard, GitHub, Hugging Face, and trust routes support direct evaluation.
Leadership and publication continuityPublic research continuity, product access, and trust materials remain visible to external evaluators.
Public timeline of research, productization, and company development
The homepage shows the public milestones that connect research, productization, and transparent company execution.
2017 publication
Screening participation barriers documented
Social Science & Medicine published field research on Roma women and cervical screening participation in Romania, including Florian Nicula and Andreea Itu.
2022 publication
Follow-up barriers researched in remote communities
BMJ Open published a protocol on facilitators and barriers to follow-up after abnormal cervical screening results, including Dr. Andreea Damian.
2024-2026 product build-out
CerviGuard moved into a live pilot surface
The public pilot, repository, and model hub provide a concrete flagship proof layer with supporting artifacts.
Current company posture
Trust and conversion routes are public
Contact, pricing, how-to-buy, proof, regulatory, and trust routes stay visible so buyers, partners, and investors can evaluate fit quickly.
Clear next steps for buyers, partners, and investors
The site keeps one primary CTA while making audience-specific entry points clear for buyers, partners, and investors.
Book demo / Request pilot
For clinics, hospitals, and operators evaluating CerviGuard or governed product rollout.
Go to contact hubResearch partnership
For institutions exploring prevention, qualitative research, or model-development collaboration.
Go to contact hubInvestor inquiry
For investors or accelerators reviewing SmartClover's healthcare AI platform, public proof, and commercial readiness.
Go to contact hubPublic diligence and buying routes
Use these routes to review proof, regulatory posture, trust, pricing, and procurement context before outreach.